Prof. Max Herzberg, the Founder and Chairperson of the Board of Vidac Pharma, is a renowned scientist and entrepreneur and one of the founding fathers of the Israel life sciences industry. Prof. Herzberg founded Orgenics and the EagerBio Group, is the co-founder of PixCell, and served as chairperson of several Israeli biotechnology companies and as chairperson of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). Prof. Herzberg holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science.
Former member of the Global Executive Comitte and Executive Vice-President of Sanofi in charge of diagnostic, agro-veterinary and capital development. Former Executive Vice-President of Institut Pasteur in charge of technology transfer. Former chairman of Cellectis. Presently seating in France, Israel, Belgium and USA at the boards of several Life Science Companies and Health Charities.
Founder and Manager and then Active Chairman of Orbotech from creation to $3.4B exit. . Mr. Richter was previously employed as a Founder by SeeRun Corp. He also served on the board at Photon Dynamics, Inc. He received his undergraduate degree from Technion-Israel Institute of Technology.
Since May 2019, Mr. Tenne has served as a financial consultant to Itamar Medical Ltd. (NADAQ and TASE: ITMR (until December 2021)). Mr. Tenne serves as a director of AudioCodes Ltd (NASDAQ and TASE: AUDC), MIND CTI Ltd (NASDAQ: MNDO), OPC Energy Ltd. (TASE: OPCE), Sapir Corp Ltd. (TASE: SPIR), Highcon Systems Ltd. (TASE: HICN) and Electreon Wireless Ltd. (TASE: ELWS). From August 2014 to April 2019, Mr. Tenne served as the VP Finance and CFO of Itamar Medical Ltd. From March 2005 until April 2013, Mr. Tenne served as the CFO of Ormat Technologies, Inc. (NYSE and TASE: ORA). From 2003 to 2005, Mr. Tenne was the CFO of Treofan Germany GmbH & Co. KG. From 1997 until 2003, Mr. Tenne was a partner in Kesselman & Kesselman, Certified Public Accountants in Israel (PwC Israel). Mr. Tenne holds a B.A. in Accounting and Economics and an M.B.A. from Tel Aviv University and is also a Certified Public Accountant in Israel.
Previous CEO of Vidac Pharma Ltd. (2013-2019). Dr. Becker brings more than 20 years of biopharmaceutical industry entrepreneurship and leadership experience to the Company, with expertise in the discovery and development of innovative novel pharmaceuticals. Dr. Becker was a founder, Director and Chief Science Officer of several Biotech companies. He holds a Ph.D from the Hebrew University of Jerusalem, and a postdoctoral training from Harvard University.